Hope comes from the umbilical cord: to patent the drug, a group of researchers from the University of Bologna after its neuroprotective effect has been shown in preclinical studies in vitro, ex vitro and in vivo
A hope for those suffering from glaucoma. From the umbilical cord new eye drops for the treatment of glaucoma, the silent ‘thief’ of sight that produces a progressive deterioration of the visual field and can lead to blindness. To patent the drug, a group of researchers from the University of Bologna after its neuroprotective effect has been shown in preclinical studies in vitro, ex vitro and in vivo.
The Unibo eyedrops are based on the properties of the blood contained in the umbilical cord. In fact, scholars have identified a series of growth factors that can counteract glaucoma. And the same reparative effects could also be effective on other types of eye degenerative diseases. The term glaucoma is identified today as a group of ocular pathologies caused by the degeneration of the central nervous system due to aging. These pathologies affect about one million peoplein Italy: it is estimated that between 1 and 2% of those over 40 and 5% of those over 70 are affected.
The eye drops developed by scholars are based on the use of a part of the blood contained in the umbilical cords that are donated at the time of birth by the mothers, after having removed the stem cells that can be used for transplantation purposes.